$0.15 0.00 (+0.07%)
11/25/2009 3:39 PM

Cortex Pharmaceuticals (COR)

CAPS Rating: No stars

The Company is engaged in the discovery, development and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders.

Results 1 - 6 of 6

Recs

0
Member Avatar mateub (92.28) Submitted: 5/21/2007 11:50:40 PM : Outperform Start Price: $3.02 COR Score: -72.14

This tiny biotech company has seen many ups and downs, but that's how small companies go. Their drug development efforts on Ampakine compounds offers hope for a range of neurological conditions, from Alzheimer's to ADHD.

Recs

0
Member Avatar frherma (< 20) Submitted: 5/8/2007 7:29:31 PM : Outperform Start Price: $2.93 COR Score: -73.04

favorable fda decision soon.

Recs

0
Member Avatar vest0r (< 20) Submitted: 5/8/2007 8:24:44 AM : Outperform Start Price: $3.05 COR Score: -73.27

Doing well this year, promising compound in the works.

Recs

0
Member Avatar judybarregar (< 20) Submitted: 5/3/2007 3:15:43 PM : Outperform Start Price: $2.89 COR Score: -73.15

I have been accumulating this stock over the last few years. It looks like it is ready to finally pay off!

Recs

0
Member Avatar nitinnp (< 20) Submitted: 10/5/2006 10:15:56 AM : Outperform Start Price: $2.98 COR Score: -82.65

once and IF, the fda removes the clinical hold on their lead compound cx717, this stock is gonna hit the highs very soon.

Recs

0
Member Avatar RBBioContest06 (30.64) Submitted: 5/31/2006 10:46:39 PM : Outperform Start Price: $3.18 COR Score: -88.89

Picked by koopish

Results 1 - 6 of 6

Featured Broker Partners